Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes:...

gan Komajda, Michel, Curtis, Paula, Hanefeld, Markolf, Beck-Nielsen, Henning, Pocock, Stuart J, Zambanini, Andrew, Jones, Nigel P, Gomis, Ramon, Home, Philip D
Cyhoeddwyd 2008

Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial

gan Nangaku, Masaomi, Hamano, Takayuki, Akizawa, Tadao, Tsubakihara, Yoshiharu, Nagai, Reiko, Okuda, Nobuhiko, Kurata, Kyo, Nagakubo, Takashi, Jones, Nigel P., Endo, Yukihiro, Cobitz, Alexander R.
Cyhoeddwyd yn Am J Nephrol (2021)

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial

gan Komajda, Michel, McMurray, John J.V., Beck-Nielsen, Henning, Gomis, Ramon, Hanefeld, Markolf, Pocock, Stuart J., Curtis, Paula S., Jones, Nigel P., Home, Philip D.
Cyhoeddwyd 2010

Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes: A substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in...

gan MacDonald, Michael R., Petrie, Mark C., Home, Philip D., Komajda, Michel, Jones, Nigel P., Beck-Nielsen, Henning, Gomis, Ramon, Hanefeld, Markolf, Pocock, Stuart J., Curtis, Paula S., McMurray, John J.V.
Cyhoeddwyd 2011